These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1163 related articles for article (PubMed ID: 12820911)
1. [Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections]. Li JT; Li Y; Wang J; Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):365-74. PubMed ID: 12820911 [TBL] [Abstract][Full Text] [Related]
2. [Surveillance of bacterial resistance in China (1998-1999)]. Li J; Weinstein AJ; Yang M; Zhonghua Yi Xue Za Zhi; 2001 Jan; 81(1):8-16. PubMed ID: 11798843 [TBL] [Abstract][Full Text] [Related]
3. [Surveillance on drug resistance of gram-negative bacilli isolated from hospital acquired infections and community acquired infections (2000 - 2001)]. Li JT; Li Y; Wang J; Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(12):1035-45. PubMed ID: 12899774 [TBL] [Abstract][Full Text] [Related]
4. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan. Chen YH; Liu CY; Lu JJ; King CH; Hsueh PR J Antimicrob Chemother; 2009 Dec; 64(6):1226-9. PubMed ID: 19833635 [TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004). Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446 [TBL] [Abstract][Full Text] [Related]
6. [Surveillance of gram positive cocci susceptibility to betalactams, glycopeptides, and other antimicrobials]. Giglio MS; Farías O; Lafourcade M; Pinto ME Rev Med Chil; 1999 Aug; 127(8):919-25. PubMed ID: 10752252 [TBL] [Abstract][Full Text] [Related]
8. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004). Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511 [TBL] [Abstract][Full Text] [Related]
9. Prospective study using standardized methodology for antimicrobial susceptibility of gram-positive cocci isolated from the Puerto Rico Medical Center. Rodríguez JL; Vázquez GJ; Bermúdez M; De Orbeta J; García Y; Rivera Y; Robledo IE P R Health Sci J; 2002 Dec; 21(4):343-7. PubMed ID: 12572243 [TBL] [Abstract][Full Text] [Related]
10. A comparison of the antimicrobial resistance patterns of gram-positive cocci isolated from community-private and university-affiliated hospitals from Puerto Rico. Vázquez GJ; Robledo IE; Arroyo A; Nadal E; Rodríguez R; Bermudez M; Colón M P R Health Sci J; 2003 Jun; 22(2):131-6. PubMed ID: 12866136 [TBL] [Abstract][Full Text] [Related]
12. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study. Wang Z; Cao B; Liu YM; Gu L; Wang C Chin Med J (Engl); 2009 Jun; 122(11):1283-8. PubMed ID: 19567138 [TBL] [Abstract][Full Text] [Related]
13. [An antimicrobial resistance surveillance of gram-positive cocci isolated from 12 teaching hospitals in China in 2009]. Sun HL; Wang H; Chen MJ; Liu YM; Hu ZD; Liao K; Chu YZ; Lei JE; Zhang B; Yu YS; Hu BJ; Sun ZY; Zhang Z; He QY Zhonghua Nei Ke Za Zhi; 2010 Sep; 49(9):735-40. PubMed ID: 21092441 [TBL] [Abstract][Full Text] [Related]
14. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci]. Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004). Sader HS; Streit JM; Fritsche TR; Jones RN Clin Microbiol Infect; 2006 Sep; 12(9):844-52. PubMed ID: 16882289 [TBL] [Abstract][Full Text] [Related]
16. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005). Sader HS; Watters AA; Fritsche TR; Jones RN BMC Infect Dis; 2007 Apr; 7():29. PubMed ID: 17442104 [TBL] [Abstract][Full Text] [Related]
17. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives. Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725 [TBL] [Abstract][Full Text] [Related]
18. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan. Huang YT; Liao CH; Teng LJ; Hsueh PR Clin Microbiol Infect; 2008 Feb; 14(2):124-9. PubMed ID: 18076671 [TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008). Sader HS; Jones RN Diagn Microbiol Infect Dis; 2009 Oct; 65(2):158-62. PubMed ID: 19748426 [TBL] [Abstract][Full Text] [Related]
20. Patterns of isolation of common gram positive bacterial pathogens and their susceptibilities to antimicrobial agents in Jimma Hospital. Gebreselassie S Ethiop Med J; 2002 Apr; 40(2):115-27. PubMed ID: 12240573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]